GenesisCare books 22% leap in turnover as demand continues to rise

Justin Hely, CEO, GenesisCare UK and Europe

Australian-owned cancer treatment network Genesis Cancer Care (GenesisCare) has continued to build momentum following the challenges of the pandemic, booking revenue growth of 22% in the year ended…

You must be a HM Subscriber to view this content.

Subscribe Now »